MODIFICATION OF PRECIPITATED MORPHINE WITHDRAWAL SYNDROME BY DRUGS AFFECTING CHOLINERGIC MECHANISMS

被引：47

作者：

JHAMANDAS, K ^{[1
]}

SUTAK, M ^{[1
]}

BELL, S ^{[1
]}

机构：

[1] QUEENS UNIV, FAC MED, DEPT PHARMACOL, KINGSTON, ONTARIO, CANADA

来源：

关键词：

D O I：

10.1016/0014-2999(73)90153-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：296 / 305

页数：10

共 24 条

[1]

ALBANUS L, 1969, ACTA PHARMACOL TOX, V27, P81

[2]

CHIOSA L, 1968, INT J NEUROPHARMACOL, V7, P161

[3]

CLOUET DH, 1972, CHEMICAL BIOLOGICAL

COLLIER, HOJ ;

SCHNEIDER, C ;

FRANCIS, DL .

[5]

CROSSLAND J, 1970, DRUGS CHOLINERGIC ME

[6]

DOUGLAS WW, 1970, PHARMACOLOGICAL BASI

[7]

GROSZ HJ, 1972, LANCET, V2, P564

[8]

GRUMBACH L, 1969, FED PROC, V28, P262

[9]

GUNNE LM, 1963, ACTA PHYSIOL SCAND, V58, P5

[10]

HALBACH H, 1963, B WORLD HEALTH ORGAN, V28, P139